Heart drug fails to boost weaning from life support in trial
NCT ID NCT04158674
First seen Feb 03, 2026 · Last updated May 21, 2026 · Updated 12 times
Summary
This study tested whether a drug called levosimendan could help people with severe heart failure successfully come off a heart-lung machine (ECLS). The trial planned to include 82 adults, but was stopped early. The goal was to see if the drug reduced the chance of needing to stay on the machine or requiring other temporary heart support.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE DECOMPENSATED HEART FAILURE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CHU Dijon Bourgogne
Dijon, 21079, France
Conditions
Explore the condition pages connected to this study.